Clinical Trial Update: Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Virexxa (Sodium Cridanimod) in combination with progestin therapy for progesterone receptor-negative recurrent or persistent e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Virexxa (Sodium Cridanimod)

Snippet

Sponsor: Kevelt AS | Conditions: Recurrent or Persistent Endometrial Carcinoma | Phase 2 | Status: UNKNOWN